Tema Heart & Health ETF Rating $34.36 0.00 (0.00%) As of 05/22/2026 03:14 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Tema Heart & Health ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.HRTS Aggregate RatingModerate Buy 2.79Holdings in HRTS have an aggregate rating of Moderate Buy based on 515 analyst ratings issued in the past year covering 22 companies (70.1% of the portfolio).HRTS Aggregate Price Target$34.36High Prediction$34.36Average Prediction$34.36Low Prediction$34.36Holdings in HRTS have an aggregate price target of $34.36 and a range of $34.36 to $34.36 covering 22 companies (70.1% of the portfolio).HRTS Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy18 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Tema Heart & Health ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 22 HRTS Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings10.89%LLYEli Lilly and Company$1,066.59+0.1%4.82 of 5 stars2.87$1,220.37 14.4%30Trending NewsAnalyst Forecast5.49%UNHUnitedHealth Group$388.420.0%4.0813 of 5 stars2.74$387.57 -0.2%27Positive NewsAnalyst Forecast4.55%RHHBYRoche$53.341.8449 of 5 stars2.45$51.50 -3.4%114.20%MRKMerck & Co., Inc.$122.55+0.1%4.3901 of 5 stars2.68$128.18 4.6%193.75%JNJJohnson & Johnson$234.67+0.1%4.3407 of 5 stars2.74$253.04 7.8%27Positive News3.69%TMOThermo Fisher Scientific$448.55+0.1%4.8537 of 5 stars2.96$616.10 37.4%23Positive NewsDividend Announcement3.41%GILDGilead Sciences$134.364.6364 of 5 stars2.86$156.93 16.8%29Trending NewsAnalyst RevisionGap Down3.18%RVMDRevolution Medicines$151.562.6504 of 5 stars3.00$111.35 -26.5%21Positive News2.91%VRTXVertex Pharmaceuticals$434.524.6057 of 5 stars2.92$555.17 27.8%25Positive News2.76%ABTAbbott Laboratories$87.42+0.0%4.9565 of 5 stars2.88$119.43 36.6%26Positive News2.64%BBIOBridgeBio Pharma$69.123.5122 of 5 stars2.88$88.90 28.6%25Gap Up2.57%CYTKCytokinetics$76.942.9512 of 5 stars2.86$99.30 29.1%22Positive News2.49%DHRDanaher$172.12+0.1%4.7538 of 5 stars2.86$238.65 38.7%22Positive News2.41%ABBVAbbVie$216.02+0.1%4.9069 of 5 stars2.88$253.43 17.3%25Positive News2.17%BMYBristol Myers Squibb$59.51+0.1%4.7416 of 5 stars2.37$61.31 3.0%19Positive News2.04%MDTMedtronic$78.66+0.1%4.9503 of 5 stars2.58$106.45 35.3%262.03%TEVATeva Pharmaceutical Industries$34.04-0.1%4.773 of 5 stars2.80$41.78 22.7%101.92%AMGNAmgen$339.304.1698 of 5 stars2.48$355.19 4.7%31Positive NewsAnalyst Upgrade1.79%MCKMcKesson$765.30-0.1%4.9371 of 5 stars2.82$968.87 26.6%17Positive News1.78%DXCMDexCom$72.104.197 of 5 stars2.92$82.21 14.0%261.75%REGNRegeneron Pharmaceuticals$638.884.644 of 5 stars2.70$792.65 24.1%271.71%BSXBoston Scientific$57.71-0.1%4.7576 of 5 stars2.93$92.71 60.6%27Buyback Announcement This page (NASDAQ:HRTS) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Heart & Health ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Heart & Health ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
